update
Wockhardt says Ireland's HPRA has recommended GMP cert renewal for Shendra site
Wockhardt says Irish regulators have recommended renewal of its Shendra, Aurangabad facility's GMP certificate.
Archives for March 7, 2017
US FDA lifts hold on Seattle Genetics' blood cancer ADC candidate
The US FDA has cleared Seattle Genetics to restart trials of its blood cancer candidate vadastuximab talirine that were halted last year after patient deaths.
Noramco planning formulation tech unit alongside opioid API business
Former J&J controlled substance API unit Noramco is to rejig its business to cater for branded and generic drug firms and companies looking for formulation tech solutions.
Richmond CRO opens up new site at London Guy’s Drug Research Unit
Richmond Pharmacology has opened up a third Phase I research centre in London Bridge, taking over the former Drug Research Unit at Guy’s teaching Hospital.
US FDA says Wockhardt's oversight of drug production inadequate
The US FDA has told Wockhardt its quality issues are company-wide, citing problems at subsidiary Morton Grove as an example in a warning letter published today.
Q&A
Top strategies for retaining CRA talent
High turnover rates among clinical research associates (CRA) continue to plague the industry – and competence and staff engagement are the "crux" of the issue, says IAOCR.
CROS NT acquires clinical division of PM Clinical Limited
CROS NT has acquired PM Clinical Limited’s clinical division in order to offer clients a “full and broad range services,” says CCO.
Cerveau tapped for Alzheimer's research
Cerveau has signed a research agreement through which it will supply its early-stage imaging agent to assess the stages of Alzheimer’s disease and other neurodegenerative diseases.
Vaxess granted $6m to develop sustained release vaccine patches
Two Bill & Melinda Gates Foundation grants will be used to develop a polio and measles rubella vaccine delivered through microneedles on a sustained-dermal patch.